Aetna agrees to sell all standalone Medicare Part D business

Today, Aetna announced an agreement to divest all of Aetna’s standalone Medicare Part D business to a subsidiary of WellCare Health Plans, Inc. (WellCare). The divestiture is subject to the completion of CVS Health’s proposed acquisition of Aetna, regulatory approvals and other customary closing conditions.

The agreement includes both Individual and Group standalone Part D members. Aetna will continue to administer and provide service and support for the plans that are impacted by this transaction throughout the 2019 benefit year to provide continuity for the Medicare beneficiaries in those plans. Members will see no change in their service, 2019 benefits, networks, formularies or premiums as a result of the sale. Members are encouraged to call the number on their Aetna member ID card if they have questions or need additional information.

It’s important to note all other plans and products, including our Individual Medicare Advantage (MA), integrated Medicare Advantage with Part D (MAPD) and standalone (MA-only) Group Medicare Advantage, Medicare Supplement, Ancillary, and Commercial plans and products, are not impacted by this sale.